FDA Adverse Event Injury Summary report: N

ACRYSOF IQ TORIC

MDR report key: 1625199 · Received March 5, 2010

Report

Report Number
1119421-2010-00232
Event Type
Injury
Date Received
March 5, 2010
Date of Event
January 4, 2010
Report Date
February 5, 2010
Manufacturer
ALCON RESEARCH. LTD. / HUNTINGTON
Product Code
MJP
PMA / PMN Number
P930014
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE PRODUCT WAS NOT RETURNED FOR ANALYSIS; THE DEVICE REMAINS IMPLANTED. RESULTS FROM THE PRODUCT HISTORY RECORD REVIEW INDICATED THE PRODUCT MET RELEASE CRITERIA. THERE HAVE BEEN NO OTHER COMPLAINTS REPORTED IN THE LOT NUMBER. AN UNAPPROVED VISCOELASTIC WAS USED DURING THE IMPLANT SURGERY. ADDITIONAL INFORMATION WAS REQUESTED ON 02/05/2010, 02/08/2010, 02/09/2010, 02/10/2010, 02/12/2010, AND 02/17/2010 BY PHONE, FAX, AND MAIL. A COMPLETED QUESTIONNAIRE WAS RECEIVED ON 02/17/2010. (B) (4)

Description of Event or Problem · 1

A SURGEON REPORTED TWO CASES OF ENDOPHTHALMITIS FOLLOWING INTRAOCULAR LENS (IOL) IMPLANT SURGERY. THE SURGEON REPORTED THE PROCEDURES WERE PERFORMED BY TWO DIFFERENT SURGEONS AT THE SAME SURGERY CENTER. THIS PATIENT WAS BILATERALLY IMPLANTED. THE SURGEON REPORTED THIS PATIENT HAS ELEVATED INTRAOCULAR PRESSURE (IOP) ON THE FIRST POSTOPERATIVE DAY. AN ANTERIOR CHAMBER PARACENTESIS WAS PERFORMED. THE IOP WAS NORMAL AT A SUBSEQUENT POSTOPERATIVE VISIT. NO CULTURES WERE PERFORMED. AN UNAPPROVED VISCOELASTIC WAS USED DURING THE IMPLANT SURGERY. A NURSE SPEAKING FOR THE SURGERY CENTER REPORTED, THE PROCEDURES WERE PERFORMED ON DIFFERENT DAYS AND IN DIFFERENT OPERATING ROOMS. THE NURSE REPORTED, THIS CASE WAS THE SECOND TO THE LAST OF THE DAY. THERE ARE THREE MEDICAL DEVICE REPORTS ASSOCIATED WITH THIS EVENT. THIS REPORT IF FOR THE SECOND SURGEON'S PATIENT, RIGHT EYE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ACRYSOF IQ TORIC INTRAOCULAR LENS MJP ALCON RESEARCH. LTD. / HUNTINGTON SN6AT5 10900644

Patients

Seq Age Sex Outcome Treatment
1 63 YR Required Intervention AMVISC